150 related articles for article (PubMed ID: 12909484)
1. Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata.
Wang H; Mahadevappa M; Yamamoto K; Wen Y; Chen B; Warrington JA; Polan ML
Fertil Steril; 2003 Aug; 80(2):266-76. PubMed ID: 12909484
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of several genes in human myometrium and uterine leiomyoma.
Roth TM; Klett C; Cowan BD
Fertil Steril; 2007 Mar; 87(3):635-41. PubMed ID: 17173903
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.
Dimitrova IK; Richer JK; Rudolph MC; Spoelstra NS; Reno EM; Medina TM; Bradford AP
Fertil Steril; 2009 Jun; 91(6):2650-63. PubMed ID: 18672237
[TBL] [Abstract][Full Text] [Related]
4. Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology.
Catherino WH; Prupas C; Tsibris JC; Leppert PC; Payson M; Nieman LK; Segars JH
Fertil Steril; 2003 Aug; 80(2):282-90. PubMed ID: 12909487
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata.
Wei JJ; Chiriboga L; Mittal K
Fertil Steril; 2005 Aug; 84(2):474-84. PubMed ID: 16084893
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.
González-Santana A; Marrero-Hernández S; Dorta I; Hernández M; Pinto FM; Báez D; Bello AR; Candenas L; Almeida TA
Fertil Steril; 2016 Nov; 106(6):1521-1529. PubMed ID: 27456549
[TBL] [Abstract][Full Text] [Related]
8. Differentially regulated expression of neurokinin B (NKB)/NK3 receptor system in uterine leiomyomata.
Cañete H; Dorta I; Hernández M; Cejudo Roman A; Candenas L; Pinto FM; Valladares F; Báez D; Montes de Oca F; Bello AR; Almeida TA
Hum Reprod; 2013 Jul; 28(7):1799-808. PubMed ID: 23656837
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium.
Kim JG; Kim MH; Kim IS; Moon SY; Kang SB; Lee HP; Lee JY
Am J Reprod Immunol; 2000 Jan; 43(1):53-7. PubMed ID: 10698042
[TBL] [Abstract][Full Text] [Related]
10. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction.
Harrison-Woolrych ML; Charnock-Jones DS; Smith SK
J Clin Endocrinol Metab; 1994 May; 78(5):1179-84. PubMed ID: 8175976
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of latent TGF-beta binding protein-1 and fibrillin-1 in human uterine leiomyomata.
Zhao Y; Wen Y; Polan ML; Qiao J; Chen BH
Mol Hum Reprod; 2007 May; 13(5):343-9. PubMed ID: 17360930
[TBL] [Abstract][Full Text] [Related]
12. Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure.
Catherino WH; Malik M
Fertil Steril; 2007 Jun; 87(6):1388-98. PubMed ID: 17276435
[TBL] [Abstract][Full Text] [Related]
13. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
Crabtree JS; Jelinsky SA; Harris HA; Choe SE; Cotreau MM; Kimberland ML; Wilson E; Saraf KA; Liu W; McCampbell AS; Dave B; Broaddus RR; Brown EL; Kao W; Skotnicki JS; Abou-Gharbia M; Winneker RC; Walker CL
Cancer Res; 2009 Aug; 69(15):6171-8. PubMed ID: 19622772
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of 14-3-3 gamma in uterine leiomyoma as identified by proteomics.
Lv J; Zhu X; Dong K; Lin Y; Hu Y; Zhu C
Fertil Steril; 2008 Nov; 90(5):1892-8. PubMed ID: 18054924
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium.
Marsh EE; Lin Z; Yin P; Milad M; Chakravarti D; Bulun SE
Fertil Steril; 2008 Jun; 89(6):1771-6. PubMed ID: 17765232
[TBL] [Abstract][Full Text] [Related]
17. Coordinated regulation of HOX gene expression in myometrium and uterine leiomyoma.
Cermik D; Arici A; Taylor HS
Fertil Steril; 2002 Nov; 78(5):979-84. PubMed ID: 12413981
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Verala J; Luo X; Xu J; Williams RS
J Soc Gynecol Investig; 2003 Apr; 10(3):161-71. PubMed ID: 12699880
[TBL] [Abstract][Full Text] [Related]
19. Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II.
Imir AG; Lin Z; Yin P; Deb S; Yilmaz B; Cetin M; Cetin A; Bulun SE
J Clin Endocrinol Metab; 2007 May; 92(5):1979-82. PubMed ID: 17341559
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.
Pan Q; Luo X; Chegini N
J Cell Mol Med; 2008; 12(1):227-40. PubMed ID: 18182067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
